Rockefeller Capital Management
NUVB icon

Rockefeller Capital Management’s Nuvation Bio NUVB Stock Holding History

Rockefeller Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.4K Buy
15,236
+12,180
+399% +$67.9K ﹤0.01% 3120
2025
Q4 		$27.4K Buy
3,056
+2,156
+240% +$13.4K ﹤0.01% 3360
2025
Q3 		$3.33K Buy
+900
New +$2.45K ﹤0.01% 3986

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rockefeller Capital Management's NUVB Position: Q1 2026 in Review

Rockefeller Capital Management increased its Nuvation Bio (NUVB) stake by 399% in Q1 2026, buying an estimated $67.9K and bringing the position to 15,236 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3120.

Rockefeller Capital Management first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Rockefeller Capital Management held 15,236 shares of Nuvation Bio worth $65.4K as of Q1 2026.
  • Rockefeller Capital Management bought 12,180 Nuvation Bio shares in Q1 2026, an estimated $67.9K.
  • Nuvation Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3120 holding.
  • Rockefeller Capital Management first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.